ENCODE, immunology, developmental biology
Passing the Torch
Passing the Torch
Mary Beth Aberlin | Dec 1, 2017
Looking back, looking forward
Immune System Targets Diverse Viruses Using the Same Small Peptide
Immune System Targets Diverse Viruses Using the Same Small Peptide
Catherine Offord | Dec 1, 2017
A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.
Captivated by Chromosomes
Captivated by Chromosomes
Anna Azvolinsky | Dec 1, 2017
Peering through a microscope since age 14, Joseph Gall, now 89, still sees wonder at the other end.
New Techniques Detail Embryos’ First Hours and Days
New Techniques Detail Embryos’ First Hours and Days
Jef Akst | Dec 1, 2017
New technologies reveal the dynamic changes in mouse and human embryos during the first week after fertilization.
Infographic: How Embryos Take Control of Their Own Development
Infographic: How Embryos Take Control of Their Own Development
Jef Akst | Nov 30, 2017
The switch from maternal factors involves dynamic reprogramming of the zygotic genome.
Image of the Day: Skate Youngsters 
Image of the Day: Skate Youngsters 
The Scientist Staff | Nov 28, 2017
Scientists study the development of scales in skate embryos. 
European Research Council Founder, Molecular Biologist Dies
European Research Council Founder, Molecular Biologist Dies
Catherine Offord | Nov 20, 2017
Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.
Researchers Build a Cancer Immunotherapy Without Immune Cells
Researchers Build a Cancer Immunotherapy Without Immune Cells
Abby Olena | Nov 13, 2017
A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 
Image of the Day: Tadpole Prism
Image of the Day: Tadpole Prism
The Scientist Staff | Nov 3, 2017
Scientists are making use of Xenopus tadpoles to study autism risk genes. 
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.